Figure 1:
Ero Copper Reports First Quarter 2023 Operating and Financial Results
08 mai 2023 17h01 HE | Ero Copper Corp.
VANCOUVER, British Columbia, May 08, 2023 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce its operating and financial results for the three...
BellRing Brands logo.png
BellRing Brands Reports Results for the Second Quarter of Fiscal Year 2023; Raises Fiscal Year 2023 Outlook
08 mai 2023 17h00 HE | BellRing Brands, Inc.
ST. LOUIS, May 08, 2023 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global convenient nutrition category, today reported results for the...
BRT Logo.jpg
BRT Apartments Corp. Reports First Quarter 2023 Results
08 mai 2023 16h15 HE | BRT Apartments Corp.
GREAT NECK, N.Y., May 08, 2023 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE: BRT), a real estate investment trust that owns, operates, and, to a lesser extent, holds interests in joint ventures...
Logo_Large_DK_RGB.png
Solid Power, Inc. Announces First Quarter 2023 Financial Results
08 mai 2023 16h10 HE | Solid Power, Inc.
LOUISVILLE, Colo., May 08, 2023 (GLOBE NEWSWIRE) -- Solid Power, Inc. (Nasdaq: SLDP), a developer of solid state battery technology, today announced its financial results for the first quarter ended...
newfhrlogo.jpg
Full House Resorts Announces First Quarter Results
08 mai 2023 16h05 HE | Full House Resorts, Inc.
- Revenues Increased 21.0% to $50.1 Million - The Temporary by American Place Officially Opened on February 17th;Illinois Sportsbook Expected to Commence Operations by August 2023 - Full Opening of...
Coherus Logo - R@2x.png
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
08 mai 2023 16h05 HE | Coherus BioSciences, Inc.
– UDENYCA® autoinjector approved and ready for May 2023 launch –– CIMERLI® product-specific Q-code now facilitating electronic reimbursement following April 1 activation –– FDA inspection of...
RevolutionLogo.png
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
08 mai 2023 16h02 HE | Revolution Medicines, Inc.
First Wave of Investigational RAS(ON) Inhibitors – RMC-6236 (RASMULTI), RMC-6291 (KRASG12C) and RMC-9805 (KRASG12D) – progressing on plan Appointment of chief medical officer and key leaders across...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Reports First Quarter 2023 Financial Results
08 mai 2023 16h01 HE | FibroGen, Inc.
• Topline Data From Four Phase 3 Trials Expected Through 3Q 2023 • Completed Non-Dilutive Term Loan Financing for up to $150 Million with Morgan Stanley Tactical Value • Entered Into...
ptx-logo .png
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
08 mai 2023 08h30 HE | Prelude Therapeutics, Inc.
Eight abstracts presented at AACR 2023 demonstrate progress of the pipeline Cash runway unchanged, supporting operations into the fourth quarter of 2024 WILMINGTON, Del., May 08, 2023 (GLOBE...
sema.jpg
Semantix Announces 1Q 2023 Financial Results
08 mai 2023 08h05 HE | Semantix, Inc.
SÃO PAULO, Brazil, May 08, 2023 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX), a leading Latin American end-to-end data and enterprise AI platform provider, today announced its financial...